About Pear Bio

About company

Pear Bio helps doctors and pharma companies evaluate cancer drug efficacy using organ-on-a-chip. It operates as a computational biology company that uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.